Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Equity: 2011-2025

Historic Return on Equity for OptimizeRx (OPRX) over the last 15 years, with Q3 2025 value amounting to 0.04%.

  • OptimizeRx's Return on Equity rose 3100.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year increase of 3100.0%. This contributed to the annual value of 0.13% for FY2024, which is 100.0% up from last year.
  • Per OptimizeRx's latest filing, its Return on Equity stood at 0.04% for Q3 2025, which was up 3100.0% from 0.04% recorded in Q2 2025.
  • OptimizeRx's Return on Equity's 5-year high stood at 0.04% during Q3 2025, with a 5-year trough of 0.27% in Q3 2024.
  • For the 5-year period, OptimizeRx's Return on Equity averaged around 0.09%, with its median value being 0.09% (2022).
  • In the last 5 years, OptimizeRx's Return on Equity plummeted by -1500bps in 2024 and then surged by 3100bps in 2025.
  • Over the past 5 years, OptimizeRx's Return on Equity (Quarter) stood at 0.0% in 2021, then tumbled by -3155bps to 0.09% in 2022, then tumbled by -132bps to 0.21% in 2023, then soared by 36bps to 0.13% in 2024, then surged by 130bps to 0.04% in 2025.
  • Its Return on Equity stands at 0.04% for Q3 2025, versus 0.04% for Q2 2025 and 0.09% for Q1 2025.